Related Experiment Videos
Interferon-alpha: regulatory effects on cell cycle and angiogenesis
Stefan Rosewicz1, Katharina Detjen, Arne Scholz
1Medizinische Klinik m.S. Hepatologie und Gastroenterologie, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
Neuroendocrinology
|October 13, 2004
Summary
Interferon-alpha (IFN-alpha) inhibits neuroendocrine tumor growth by slowing cell cycle progression and reducing vascular endothelial growth factor (VEGF) expression, thereby inhibiting tumor angiogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies.
- Understanding the molecular mechanisms regulating NET proliferation and angiogenesis is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the effects of interferon-alpha (IFN-alpha) on the proliferation and angiogenesis of neuroendocrine tumors.
- To elucidate the molecular pathways targeted by IFN-alpha in NET cells.
Main Methods:
- Utilized human NET cell lines to assess IFN-alpha signaling via STAT activation.
- Analyzed cell cycle progression, cyclin B levels, and Cdc2 kinase activity.
- Quantified VEGF gene transcription and promoter activity.
- Evaluated IFN-alpha effects in NET xenograft models and patient liver metastases.
Main Results:
- IFN-alpha demonstrated functional signaling in NET cells, inhibiting anchorage-dependent and -independent growth by delaying cell cycle progression.
- IFN-alpha reduced cyclin B levels and Cdc2 kinase activity, contributing to growth inhibition.
- IFN-alpha significantly suppressed VEGF gene transcription through Sp1/Sp3-dependent inhibition of the VEGF promoter.
- In vivo studies showed that IFN-alpha treatment inhibited NET growth and angiogenesis in mice and decreased VEGF expression and angiogenesis in human NET liver metastases.
Conclusions:
- IFN-alpha exerts direct antiproliferative effects on neuroendocrine tumors.
- IFN-alpha inhibits tumor angiogenesis by suppressing VEGF gene expression.
- IFN-alpha represents a potential therapeutic agent for neuroendocrine tumor disease through combined antiproliferative and anti-angiogenic mechanisms.